Related Experiment Video
Updated: Jul 9, 2026
Protein Purification-free Method of Binding Affinity Determination by Microscale Thermophoresis
Published on: August 15, 2013
Computational study on mechanism of G-quartet oligonucleotide T40214 selectively targeting Stat3
1Department of Medicine, Baylor College of Medicine, One Baylor Plaza, N1317.05, Houston, TX 77030, USA.
Abstract:
The mounting evidences have shown that signal transducer and activator of transcription 3 (Stat3) is a critical target for cancer therapy. Recently, we developed a G-quartet oligonucleotide T40214 as a novel and potent Stat3 inhibitor. T40214 specifically inhibited DNA-binding activity of Stat3 and significantly suppressed the growth of many tumor xenografts in nude mice. To determine the mechanism of GQ-ODNs selectively targeting Stat3, we established a 3D model of complex T40214/p-Stat3 dimer based on experimental evidences. The binding site of T40214 within Stat3 dimer was determined by statistical docking analysis. The results indicated that T40214 strongly interacted within the region from residue E638 through E652 of Stat3 dimer. The binding model refined by Hex docking disclosed that T40214 binds to SH2 domain of Stat3 and forms H-bonds with residues Q643, Q644, N646, and N647, which are critical for the binding interaction. The 3D models also suggested that T40214 inhibits Stat3 activity through disrupting the binding interaction between Stat3 dimer and DNA duplex for transcription. Our computational studies provided a platform for future structure-based drug design of novel Stat3 inhibitors.
Insights
A novel G-quartet oligonucleotide, T40214, effectively inhibits signal transducer and activator of transcription 3 (Stat3) by binding to its SH2 domain. This targeted inhibition suppresses tumor growth, offering a new avenue for cancer therapy.
Area of Science:
- Oncology
- Molecular Biology
- Drug Discovery
Background:
- Signal transducer and activator of transcription 3 (Stat3) is a key target in cancer therapy.
- G-quartet oligonucleotides (GQ-ODNs) represent a novel class of Stat3 inhibitors.
Purpose of the Study:
- To elucidate the mechanism by which GQ-ODN T40214 selectively targets and inhibits Stat3.
- To provide a structural basis for the rational design of future Stat3 inhibitors.
Main Methods:
- Development of a G-quartet oligonucleotide (T40214) as a Stat3 inhibitor.
- In vitro assessment of T40214's inhibition of Stat3 DNA-binding activity.
- In vivo evaluation of T40214's efficacy in suppressing tumor xenograft growth.
- Establishment of a 3D model for the T40214/p-Stat3 dimer complex.
- Statistical and Hex docking analyses to determine the binding site and interactions.
Main Results:
- T40214 demonstrated potent inhibition of Stat3 DNA-binding activity and suppressed tumor xenograft growth in mice.
- 3D modeling identified the binding site of T40214 within the SH2 domain of the Stat3 dimer (residues E638-E652).
- T40214 forms critical hydrogen bonds with Stat3 residues Q643, Q644, N646, and N647.
- The binding of T40214 disrupts the interaction between Stat3 dimers and DNA, inhibiting transcriptional activity.
Conclusions:
- T40214 is a potent Stat3 inhibitor with therapeutic potential in cancer.
- Computational modeling provides crucial insights into the structure-based mechanism of GQ-ODN inhibition of Stat3.
- This study lays the groundwork for structure-based drug design of novel Stat3-targeting cancer therapeutics.
Related Concept Videos
01:20The JAK-STAT Signaling Pathway
02:04Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.